Esperion Therapeutics Inc... (ESPR)
NASDAQ: ESPR
· Real-Time Price · USD
2.10
0.03 (1.45%)
At close: Aug 15, 2025, 2:35 PM
Esperion Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 86.06M | 114.63M | 144.76M | 144.72M | 189.3M | 226.61M | 82.25M | 114.83M | 138.47M | 144.91M | 124.78M | 159.4M | 122.94M | 150.36M | 208.89M | 103.67M | 219.19M | 217.94M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 17.43M | 42.09M | 29.94M | 62.91M | 68.14M | 50.44M | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 42.09M | 50M | 62.91M | 50M | 50.44M | 50M | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.5M | -1.21M | -42.09M | 50M | -12.9M | n/a | 50M | n/a | n/a | n/a |
Receivables | n/a | 81.29M | 80.14M | 67.82M | 60.36M | 54.61M | 48.49M | 42.62M | 40.8M | 36.41M | 33.73M | 31.49M | 27.84M | 25.12M | 22.93M | 21.71M | 21.85M | n/a |
Inventory | n/a | 99.32M | 94.49M | 80.1M | 84.47M | 73.09M | 65.62M | 51.44M | 45.68M | 39.35M | 35.2M | 29.55M | 29.23M | 35.65M | 34.39M | 33.97M | 23.71M | 20.03M |
Other Current Assets | n/a | 4.82M | 18.02M | 14.91M | n/a | 11.29M | n/a | 6.29M | 4.32M | 5.58M | 9.87M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 86.06M | 318.78M | 338M | 307.56M | 345.11M | 365.61M | 201.06M | 218.23M | 232.13M | 250.6M | 246.68M | 261.79M | 252.48M | 290.82M | 328.97M | 170.67M | 275.17M | 272.57M |
Property-Plant & Equipment | n/a | 5.2M | 5.77M | 6.5M | 7.16M | 7.4M | 4.67M | 3.02M | 2.44M | 1.16M | 1.2M | 986K | 1.45M | 1.98M | 2.56M | 4.53M | 5.23M | 5.97M |
Goodwill & Intangibles | n/a | 56K | 56K | 56K | 56K | 56K | 56K | 56K | 56K | 56K | 56K | 56K | 56K | 56K | 56K | 56K | 56K | 56K |
Total Long-Term Assets | n/a | 5.25M | 5.82M | 6.56M | 7.21M | 7.45M | 4.73M | 3.08M | 2.5M | 1.21M | 1.26M | 51.04M | 51.5M | 52.03M | 52.62M | 54.59M | 5.29M | 6.03M |
Total Assets | 355.02M | 324.03M | 343.82M | 314.11M | 352.32M | 373.06M | 205.8M | 221.31M | 234.63M | 251.82M | 247.94M | 312.83M | 303.98M | 342.85M | 381.59M | 225.26M | 280.46M | 278.61M |
Account Payables | n/a | 71.99M | 51.65M | 34.86M | 47.67M | 28.43M | 31.72M | 26.21M | 24.56M | 17.07M | 23.04M | 18.58M | 12.83M | 26.83M | 17.56M | 20.75M | 29.35M | 30.34M |
Deferred Revenue | n/a | 4.54M | 8.52M | 15.08M | 20.67M | 29.35M | 25.4M | 19.72M | 15.63M | 12.16M | 3.51M | 4.04M | 5.03M | 3.79M | 5.68M | 3.07M | 3.93M | 2.54M |
Short-Term Debt | n/a | 54.67M | 54.58M | n/a | n/a | 43.49M | 34.83M | 37.01M | 22.78M | 26.92M | 24.76M | 19.64M | 21.97M | 13.39M | 11.29M | 14.05M | 12.47M | 6.35M |
Other Current Liabilities | n/a | 63.66M | 60.33M | 49.53M | 40.23M | 54.74M | 49.24M | 45.59M | 36.52M | 33.47M | 29.02M | 30.88M | 33.94M | 27.52M | 24.7M | 27.3M | 22.13M | 45.07M |
Total Current Liabilities | n/a | 270.97M | 246.23M | 165.87M | 175.34M | 164.51M | 156.22M | 137.71M | 107.17M | 95.49M | 92.31M | 82.34M | 82.28M | 79.08M | 73.35M | 78.48M | 82.64M | 97.89M |
Long-Term Debt | 146.45M | 238.32M | 237.72M | 262.92M | 262.48M | 498.43M | 501.55M | 261.17M | 260.74M | 260.32M | 478.74M | 259.49M | 259.08M | 258.68M | 504.02M | 272.51M | 272.1M | 271.69M |
Other Long-Term Liabilities | n/a | 238.98M | 246.02M | 252.23M | 254.75M | n/a | n/a | 230.39M | 236.99M | 224.9M | n/a | 265.05M | 253.98M | 253.44M | n/a | 234.81M | 227.05M | 175.89M |
Total Long-Term Liabilities | 146.45M | 479.27M | 486.31M | 518.45M | 521.2M | 502.85M | 504.57M | 493.6M | 499.43M | 486M | 479.41M | 524.58M | 513.4M | 512.81M | 505.18M | 509.48M | 502.13M | 450.11M |
Total Liabilities | n/a | 750.24M | 732.54M | 684.32M | 696.54M | 667.36M | 660.79M | 631.31M | 606.6M | 581.48M | 571.72M | 606.93M | 595.68M | 591.89M | 578.53M | 587.96M | 584.77M | 548M |
Total Debt | 146.45M | 297.78M | 297.6M | 268.96M | 556.63M | 548.87M | 540.95M | 264.13M | 263.13M | 261.4M | 260.95M | 260.23M | 260.17M | 260.16M | 260.2M | 276.22M | 276.36M | 276.55M |
Common Stock | 200K | 197K | 196K | 195K | 195K | 188K | 118K | 112K | 101K | 87K | 75K | 72K | 65K | 61K | 61K | 27K | 26K | 26K |
Retained Earnings | -1.65B | -1.64B | -1.6B | -1.58B | -1.55B | -1.49B | -1.55B | -1.49B | -1.45B | -1.4B | -1.34B | -1.28B | -1.23B | -1.16B | -1.11B | -1.04B | -971.87M | -928.2M |
Comprehensive Income | n/a | n/a | n/a | n/a | -0.00 | 0.00 | -0.00 | 0.00 | 0.00 | -1K | -2K | -93K | -297K | -263K | -31K | 0.00 | 0.00 | -0.00 |
Shareholders Equity | n/a | -426.21M | -388.72M | -370.21M | -344.22M | -294.3M | -454.99M | -410M | -371.98M | -1.4B | -1.34B | -294.1M | -1.23B | -249.04M | -196.94M | -362.7M | -304.31M | -269.39M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 17.43M | 84.17M | 29.94M | 125.81M | 68.14M | 100.88M | 50M | n/a | n/a |